Osteoporosis

Paperback | February 12, 2013

byRonald C. Hamdy, E. Michael Lewiecki

not yet rated|write a review
Osteoporosis is a common, underdiagnosed, and undertreated condition, complicated by fractures which lead to significant mortality and morbidity. The prevalence of osteoporotic fractures in postmenopausal women exceeds the combined prevalence of breast cancer, stroke, heart failure, andmyocardial infarction. Often called "the silent disease," it does not reveal itself with obvious symptoms until a fracture occurs. In the first year after sustaining a hip fracture, mortality is increased by almost 24% in women and is even higher in men. About half of those who sustain anosteoporotic hip fracture become so disabled that they are no longer able to resume their daily activities, and as many as 20% require long-term institutional care. Effective treatments for osteoporosis are now available if it is diagnosed and addressed in a timely manner. Unfortunately, thisdisease remains shockingly underdiagnosed and undertreated, even in patients who sustain low-trauma hip fractures.The past two decades have witnessed radical changes in the diagnosis and management of osteoporosis. The densitometric diagnosis of osteoporosis is noninvasive, quick, and relatively simple. Tools are now available to predict the patient's probability of sustaining fractures, to identify patientswho are particularly vulnerable, and to determine which patients will benefit from further investigation and treatment. Various associations have developed guidelines to help clinicians reach a diagnosis and initiate treatment. Due to better understanding of the basic pathophysiology of boneturnover, potent and relatively safe medications that significantly reduce the risk of fractures are now widely available. It is of paramount importance that this disease be diagnosed and treated as early as possible in order to take advantage of these developments and reduce the enormoussocioeconomic and psychological impact of osteoporosis.Given the burden of osteoporotic fractures, all clinicians should have a working knowledge of e diagnosis, treatment, and prevention of the disease. Clinicians should feel comfortable diagnosing and initiating treatment for the majority of patients with osteoporosis. Only complicated cases orpatients who are unresponsive to treatment should be referred to specialists. The aim of this book is to distill the available information on osteoporosis into an easily comprehensible format that will serve as a practical guide for busy clinicians. Numerous boxes, tables, diagrams, and figurespresent the information in an accessible manner. This book will be of particular use to general practitioners, endocrinologists, rheumatologists, gynecologists, internists, geriatricians, and orthopedic surgeons.

Pricing and Purchase Info

$29.28 online
$42.95 list price (save 31%)
Ships within 1-3 weeks
Ships free on orders over $25

From the Publisher

Osteoporosis is a common, underdiagnosed, and undertreated condition, complicated by fractures which lead to significant mortality and morbidity. The prevalence of osteoporotic fractures in postmenopausal women exceeds the combined prevalence of breast cancer, stroke, heart failure, andmyocardial infarction. Often called "the silent di...

Dr. Hamdy is actively involved in clinical practice, medical education and research. In 2011 he was awarded the Clinician of the year award by the International Society of Clinical Densitometry. For the past 25 years, he has directed a number of educational programs on osteoporosis including the Southern Medical Association annual Oste...
Format:PaperbackDimensions:192 pages, 8 × 5 × 0.68 inPublished:February 12, 2013Publisher:Oxford University PressLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:0199927707

ISBN - 13:9780199927708

Look for similar items by category:

Customer Reviews of Osteoporosis

Reviews

Extra Content

Table of Contents

1. 1. Definition and Epidemiology2. Basic Bone Pathophysiology3. Bone Densitometry4. Diagnosis5. Identifying Patients at Risk of Fractures6. Non-Pharmacologic Management of Osteopenia and Osteoporosis7. Pharmacologic Management of Osteoporosis, Part 18. Pharmacologic Management of Osteoporosis, Part 29. Monitoring Patients on Treatment10. Vertebral Augmentation Procedures11. Corticosteroid-Induced Bone Loss12. Primary Hyperparathyroidism13. Premenopausal Women14. Men15. Atypical Femoral Shaft Fractures16. Osteonecrosis of the Jaw17. Osteoporosis in Children and Adolescents